Back to mobile site

Canaccord Genuity Reiterates a 'Buy' on NuVasive (NUVA); Raising PT on Continued Growth Across All Business Segments

May 1, 2012 9:47 AM EDT
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%

Rating Summary:
    11 Buy, 21 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on NuVasive (NASDAQ: NUVA) price target raised from $21 to $27.

Analyst, William J. Plovanic, said, "We reiterate our rating on NuVasive following a strong quarter that offered signs that robust top-line growth is still possible with a stabilizing macro spine backdrop. NuVasive handily beat revenue expectations across all business segments, likely taking share. Additionally, we believe integration synergies, international expansion, and new product launches provide upside to our current expectations."

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $16.57 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change